Skip to main content

Mitchell Eric Horwitz

Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710

Overview


Allogeneic stem cell transplantation with a focus on the use of umbilical cord blood grafts; Allogenic stem cell transplantation for Sickle Cell Disease; Prevention of acute and chronic graft versus host disease; Improving immune recovery following alternative donor stem cell transplantation using donor graft manipulation.

Current Appointments & Affiliations


Professor of Medicine · 2016 - Present Medicine, Hematologic Malignancies and Cellular Therapy, Medicine
Member of the Duke Cancer Institute · 2003 - Present Duke Cancer Institute, Institutes and Centers
Affiliate of the Duke Regeneration Center · 2021 - Present Duke Regeneration Center, Basic Science Departments

In the News


Published May 17, 2023
More Options for People With Blood Cancer
Published December 5, 2018
Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants

View All News

Recent Publications


Long-Term Toxicity after Non-Myeloablative Conditioning Regimens Using Total Body Irradiation.

Journal Article Adv Radiat Oncol · April 2025 PURPOSE: To evaluate long-term health risks after allogeneic hematopoietic stem cell transplantation (HSCT) using non-myeloablative total body irradiation (TBI). METHODS AND MATERIALS: All adult patients undergoing non-myeloablative allogeneic HSCT using T ... Full text Link to item Cite

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.

Journal Article Support Care Cancer · November 28, 2024 UNLABELLED: Hematopoietic cell transplantation (HCT) is a promising treatment for hematologic malignancies, but intensive conditioning leads to immunosuppression and susceptibility to healthcare-associated infections (HAI). Despite standard prevention meas ... Full text Link to item Cite

Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.

Journal Article EClinicalMedicine · October 2024 BACKGROUND: Almost all acquired severe aplastic anaemia is immune mediated and characterised by hypocellular bone marrow and ≥2 affected haematopoietic lineages. The optimal preparartive regimen for unrelated donor transplantation remains to be established ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


Rush University · 1992 M.D.